Latest AI and machine learning research in hemophilia for healthcare professionals.
Dual antiplatelet therapy (DAPT), combining aspirin with a P2Y12 inhibitor, remains central to secon...
BACKGROUND: Inherited PLN (phospholamban) R14del variants cause dilated cardiomyopathy with a high b...
Pyroptosis is a major contributor to the pathophysiology of acute liver failure (ALF), a condition w...
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with limited mechanism-based therapi...
BACKGROUND: A major challenge facing prostate cancer (PCa) cells is oxidative stress, yet the precis...
Poly(adenosine diphosphate-ribose) polymerase 1 (PARP1) is a pivotal target for treating homologous ...
Viral proteases are critical targets in antiviral drug development due to their essential role in th...
BACKGROUND: KRAS-mutant lung adenocarcinoma (LUAD) is associated with aggressive phenotypes and ther...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) strongly resists apoptosis via baculoviral inhib...
BACKGROUND: Postoperative nausea and vomiting (PONV) remains a prevalent complication hindering Enha...
Breast cancer is one of the most prevalent and lethal malignancies affecting women globally. The inc...
BACKGROUND: Colorectal cancer (CRC) is one of the most common malignancies worldwide and remains a m...
The proliferation of phosphodiesterase-5 inhibitor (PDE5I) derivatives in food products and environm...
Vasculogenic mimicry (VM), a novel endothelial-independent blood perfusion pathway, is linked to adv...
Protein-protein interactions (PPIs) are shaped by evolutionary pressures that fine-tune binding affi...
The phosphatidylinositol 3-kinase (PI3K) pathway is a vital intracellular signaling cascade that pla...
CaMKIIα is a central regulator of synaptic plasticity and memory, and its pathological overactivatio...
BACKGROUND: Ferroptosis, a form of regulated cell death driven by iron-dependent lipid peroxidation,...
Backbone cyclization and disulfide bonding are key global covalent constraints in many bioactive pep...
BACKGROUND: ∼60%-70% of patients with metastatic non-small cell lung cancer (NSCLC) have relatively ...